Jeff Aronin (born December 8, 1967) is an American investor, entrepreneur, and biopharmaceutical executive.
He is chairman and CEO of Paragon Biosciences, LLC, an innovation-based life sciences company that develops, accelerates and finances new companies that create major biotechnology advancements to improve patient care.
Paragon Biosciences’ companies focus on patients suffering from debilitating diseases with no effective treatment.
The Paragon Biosciences team has succeeded in getting 13 Novel Drug Approvals through the FDA.
Aronin is also chairman, CEO and founder of Paragon Pharmaceutical Capital, LLC, an investment firm that backs healthcare companies.